CN110305178B - Synthetic method of ursodeoxycholic acid - Google Patents
Synthetic method of ursodeoxycholic acid Download PDFInfo
- Publication number
- CN110305178B CN110305178B CN201910657023.2A CN201910657023A CN110305178B CN 110305178 B CN110305178 B CN 110305178B CN 201910657023 A CN201910657023 A CN 201910657023A CN 110305178 B CN110305178 B CN 110305178B
- Authority
- CN
- China
- Prior art keywords
- reaction
- solvent
- acid
- ursodeoxycholic acid
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title claims abstract description 49
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 title claims abstract description 44
- 229960001661 ursodiol Drugs 0.000 title claims abstract description 44
- 238000010189 synthetic method Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 99
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000004380 Cholic acid Substances 0.000 claims abstract description 32
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims abstract description 32
- 229960002471 cholic acid Drugs 0.000 claims abstract description 32
- 235000019416 cholic acid Nutrition 0.000 claims abstract description 32
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000006722 reduction reaction Methods 0.000 claims abstract description 17
- 230000009467 reduction Effects 0.000 claims abstract description 15
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 12
- 239000012038 nucleophile Substances 0.000 claims abstract description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 87
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 42
- 239000002904 solvent Substances 0.000 claims description 41
- 238000001914 filtration Methods 0.000 claims description 21
- 238000001704 evaporation Methods 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 16
- 238000005886 esterification reaction Methods 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 10
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 claims description 10
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 claims description 9
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 239000007800 oxidant agent Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- 230000006103 sulfonylation Effects 0.000 claims description 6
- 238000005694 sulfonylation reaction Methods 0.000 claims description 6
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- ZBXNFTFKKOSPLD-UHFFFAOYSA-N 5-methylsulfanyl-2h-tetrazole Chemical compound CSC1=NN=NN1 ZBXNFTFKKOSPLD-UHFFFAOYSA-N 0.000 claims description 4
- CRELSFHXXVCUIE-UHFFFAOYSA-N 5-phenyl-1-sulfanyltetrazole Chemical compound SN1N=NN=C1C1=CC=CC=C1 CRELSFHXXVCUIE-UHFFFAOYSA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 238000006477 desulfuration reaction Methods 0.000 claims description 4
- 230000023556 desulfurization Effects 0.000 claims description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 239000012434 nucleophilic reagent Substances 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 claims description 4
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 claims description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 4
- 150000003573 thiols Chemical class 0.000 claims description 4
- 101710088194 Dehydrogenase Proteins 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- AEUVIXACNOXTBX-UHFFFAOYSA-N 1-sulfanylpropan-1-ol Chemical compound CCC(O)S AEUVIXACNOXTBX-UHFFFAOYSA-N 0.000 claims description 2
- 230000010933 acylation Effects 0.000 claims description 2
- 238000005917 acylation reaction Methods 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 claims description 2
- WQABCVAJNWAXTE-UHFFFAOYSA-N dimercaprol Chemical compound OCC(S)CS WQABCVAJNWAXTE-UHFFFAOYSA-N 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- NCNISYUOWMIOPI-UHFFFAOYSA-N propane-1,1-dithiol Chemical compound CCC(S)S NCNISYUOWMIOPI-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 claims description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims 2
- 229940071127 thioglycolate Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract description 4
- 125000000101 thioether group Chemical group 0.000 abstract description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 238000010531 catalytic reduction reaction Methods 0.000 abstract 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- 238000004809 thin layer chromatography Methods 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- 238000003756 stirring Methods 0.000 description 31
- 239000007787 solid Substances 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- 238000005406 washing Methods 0.000 description 15
- 210000000941 bile Anatomy 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 11
- 229910002027 silica gel Inorganic materials 0.000 description 11
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 8
- RHCPKKNRWFXMAT-RRWYKFPJSA-N 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanic acid Chemical compound C1C[C@@H](O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)[C@@H](O)C[C@@H]3[C@]21C RHCPKKNRWFXMAT-RRWYKFPJSA-N 0.000 description 7
- 239000003613 bile acid Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229910052759 nickel Inorganic materials 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 239000002893 slag Substances 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 5
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 5
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 5
- 150000001844 chromium Chemical class 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- DGABKXLVXPYZII-UHFFFAOYSA-N Hyodeoxycholic acid Natural products C1C(O)C2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 DGABKXLVXPYZII-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- DGABKXLVXPYZII-SIBKNCMHSA-N hyodeoxycholic acid Chemical compound C([C@H]1[C@@H](O)C2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 DGABKXLVXPYZII-SIBKNCMHSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
- 206010008635 Cholestasis Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 2
- 238000006856 Wolf-Kishner-Huang Minlon reduction reaction Methods 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 230000007870 cholestasis Effects 0.000 description 2
- 231100000359 cholestasis Toxicity 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RHCPKKNRWFXMAT-NQONVGTBSA-N (4r)-4-[(8r,9s,10s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid Chemical compound C1CC(O)CC2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(O)C[C@@H]3[C@]21C RHCPKKNRWFXMAT-NQONVGTBSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- FBHJJGWRDXNKKY-UHFFFAOYSA-N 3h-dithiole;ethane-1,2-diol Chemical compound OCCO.C1SSC=C1 FBHJJGWRDXNKKY-UHFFFAOYSA-N 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000006154 Chronic hepatitis C Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- BHTRKEVKTKCXOH-UHFFFAOYSA-N Taurochenodesoxycholsaeure Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)CC2 BHTRKEVKTKCXOH-UHFFFAOYSA-N 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical group 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- -1 and further Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 201000001493 benign recurrent intrahepatic cholestasis Diseases 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Inorganic materials Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000021190 leftovers Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- BHTRKEVKTKCXOH-LBSADWJPSA-N tauroursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)CC1 BHTRKEVKTKCXOH-LBSADWJPSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention belongs to the technical field of synthetic chemistry application and biological medicine, and particularly relates to a novel method for synthesizing ursodeoxycholic acid from cholic acid, which comprises the steps of modifying 12-position hydroxyl of cholic acid into an easily-leaving group after 3, 7-position hydroxyl of the cholic acid is properly protected, using a sulfur nucleophile to attack and replace 12-position hydroxyl into a thioether group, using Raney Ni to reduce and remove the 12-position thioether group to obtain protected 3-hydroxyl-7-ketocholic acid, and carrying out asymmetric reduction or enzyme catalytic reduction on the compound to obtain the ursodeoxycholic acid. The method avoids the oxidation state raising process of the 12 th site, has simple and convenient operation, mild reaction conditions and excellent yield of each step, and has obvious advantages compared with the prior hydrazine hydrate reduction through 12 carbonyl.
Description
Technical Field
The invention belongs to the technical field of synthetic chemistry application and biological medicine, and particularly relates to a novel method for synthesizing ursodeoxycholic acid from cholic acid.
Background
Bile is a product continuously secreted by human or vertebrate liver cells, is a viscous colored alkaline liquid with bitter taste, and comprises, in addition to water, mainly bile acids, bile salts and cholesterol pigments, and in addition, small amounts of cholesterol, fatty acids, lecithin, electrolytes, proteins, etc. The bile of animal which is common nowadays is generally bird bile, pig bile, ox bile, bear bile and snake bile, etc. The bile acid is the main component of the bile, accounts for about 50-70% of the total amount of the bile, the physiological action of the bile is mainly exerted by the bile acid, and when the bile acid is used as a medicament, the bile acid can be used for clearing heat, relieving spasm and cough, regulating blood pressure, strengthening heart and benefiting gallbladder, inhibiting bacteria and resisting inflammation, regulating immunity and the like, has strong activity, small side effect and low price, and is popular with wide medicament users.
Ursodeoxycholic acid (UDCA) is the main component of bear bile, has the chemical name of 3a,7 β -dihydroxy-5 β -cholestane-24-acid, has the same molecular formula and different stereo structure with chenodeoxycholic acid and taurocholic acid, and is chemically called isomer according to the structural relationship of the two compounds.
Ursodeoxycholic acid is a non-toxic hydrophilic cholic acid, can competitively inhibit the absorption of toxic endogenous cholic acid in ileum, and can reduce the concentration of endogenous vegetable cholic acid in blood and liver cells to achieve the effect of resisting cholestasis by activating a signal network consisting of calcium ions and protein kinase C and activating division active protein kinase to enhance the secretory capacity of cholestasis liver cells. Ursodeoxycholic acid also competitively displaces toxic bile acid molecules on cell membranes and organelles, preventing liver cells and bile duct cells from being damaged by more toxic bile acids. Clinically, ursodeoxycholic acid is mainly used for dissolving cholesterol type hepatobiliary calculus, Primary Biliary Cirrhosis (PBC) and chronic hepatitis C, is also used for alcoholic liver diseases, non-alcoholic fatty liver, benign recurrent intrahepatic cholestasis and congenital cholecystic dilatation, and is an important medicine for treating hepatobiliary diseases. The medicine is mainly prepared from chenodeoxycholic acid extracted and purified from chicken and duck bile in China, and a target product ursodeoxycholic acid is obtained through 7-position oxidation and high stereoselectivity reduction. With the increasing demand of domestic and foreign markets for ursodeoxycholic acid, the sources of chickens and ducks are increasingly tense, and cholic acid from big livestock such as flocks and herds becomes an important raw material of the ursodeoxycholic acid.
The core chemical step of synthesizing ursodeoxycholic acid from cholic acid is the elimination of 12-hydroxyl group of cholic acid. The elimination process of the prior art is to oxidize the 12-hydroxyl to carbonyl and then reduce the carbonyl to methylene by using a Huang Minlon modified hydrazine hydrate reduction method or reduce the carbonyl by using zinc powder under acidic conditions. Huang Minlon reduction and zinc powder reduction under acidic conditions have unstable yield and more side reactions, and the oxidation state of hydroxyl is firstly increased and then reduced in the process, so that the method is not an atom economic reaction.
Chinese patent application CN102453071A reports a preparation method for directly extracting and synthesizing chenodeoxycholic acid and ursodeoxycholic acid from pig bile paste or leftovers, which has the following problems: hyodeoxycholic acid is not extracted, but the property of hyodeoxycholic acid is similar to that of chenodeoxycholic acid, so that the additional value is reduced, and the steric effect of the subsequent reaction is increased; the oxidation reaction of bromine water is strong and difficult to control, and side reactions are more, such as peroxide 3, 7-diketolithocholic acid, thus the conversion rate is reduced and impurities are increased; as the metal sodium and the metal potassium belong to active metals, the hydrogenation reaction is strong, not only is difficult to control, but also has potential safety hazard and must be stored in paraffin or kerosene; the purification process is insufficient, and impurities such as hyodeoxycholic acid, incompletely reacted chenodeoxycholic acid, over-reacted 3, 7-diketolithocholic acid derivatives and the like cannot be removed only by one-step acidification and precipitation.
Chinese patent application CN102477059A reports a high purity tauroursodeoxycholic acid and its preparation method, which has the following problems: the synthesized mixed anhydride is unstable, is easy to decompose when meeting water and racemize when meeting heat, so that the conversion rate is low, and the low-temperature reaction condition is difficult to control; and triethylamine and ethyl chloroformate in the used raw materials have certain toxicity, residues of the triethylamine and the ethyl chloroformate are easy to adsorb and embed in coarse crystals, and the residues are difficult to remove by water washing because the residues are insoluble in water.
Disclosure of Invention
In order to solve the technical problems, the invention provides the synthesis method of ursodeoxycholic acid, which has the advantages of mild reaction conditions, simple operation, less prepared byproducts, high yield and high purity.
In order to achieve the above purpose, the invention provides the following technical scheme:
a synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) dissolving cholic acid in a solvent, adding an oxidant, and stirring for reaction to obtain an intermediate 1 (7-keto-3, 12-dihydroxycholanic acid);
(2) adding the intermediate 1 into an alcohol solvent for esterification reaction, evaporating the solvent after the reaction is finished, adding an acylation reagent for reaction, and processing to obtain an intermediate 2;
(3) dissolving the dried intermediate 2 in an organic solvent, cooling, adding a sulfonylation reagent for reaction, and processing to obtain an intermediate 3;
(4) dissolving the intermediate 3 in a solvent, adding a sulfhydryl nucleophilic reagent, reacting, and treating to obtain an intermediate 4 (the 12-carbon has a thioether group);
(5) dissolving the intermediate 4 in a solvent, adding a reducing agent, heating, carrying out reduction desulfurization reaction, filtering after the reaction is finished to obtain a filtrate, adding alcohol and alkali into the filtrate, carrying out hydrolysis reaction, and then carrying out acidification treatment to obtain an important intermediate 5 (7-ketocholic acid) in ursodeoxycholic acid synthesis;
(6) adding the intermediate 5 into an alcohol solvent, and carrying out reduction reaction to obtain a final product ursodeoxycholic acid;
preferably, in the step (1), the oxidant is at least one of bromine, bleaching water, PCC (pyridinium chlorochromate), PDC (pyridinium dichromate);
preferably, in step (1), the oxidizing agent is a 7- β dehydrogenase;
preferably, in step (1), the reaction is effected in an electrolytic cell by a bromide-mediated indirect electro-oxidation process;
preferably, in the step (1), the molar ratio of the oxidant to the cholic acid is 1-3: 1;
preferably, in step (2), the esterification reaction is carried out under acid-catalyzed or base-catalyzed conditions;
preferably, in step (2), the acylating agent is an acid anhydride or an acid chloride;
preferably, in the step (2), the mole ratio of the acylating agent to cholic acid is 10-30: 1;
preferably, in the step (2), the reaction temperature after adding the acylating agent is 90-100 ℃;
preferably, in the step (3), the sulfonylation reagent is at least one of tosylate, benzene sulfonyl chloride, methane sulfonyl chloride and trifluoromethanesulfonic anhydride; preferably trifluoromethanesulfonic anhydride;
preferably, in the step (3), the amount of the sulfonylation reagent is 1-2: 1;
preferably, in the step (3), the temperature of the reaction is 0-40 ℃;
preferably, in step (4), the thiol nucleophile is at least one of methyl mercaptan, ethyl mercaptan, propyl mercaptan, benzyl mercaptan, thiophenol, 2-mercaptobenzothiazole, 5-phenyl-mercaptotetrazole, 5-methylmercaptotetrazole, 2-mercaptopyridine, thioglycolic acid and thioglycolate salt, mercaptopropanol, dimercaptopropanol, ethanedithiol, and propanedithiol; preferably: at least one of 2-mercaptobenzothiazole, 5-phenyl-mercaptotetrazole, 5-methylmercaptotetrazole, and 2-mercaptopyridine;
preferably, in step (4), the molar ratio of the sulfhydryl nucleophile to cholic acid is 1-3: 1;
preferably, in the step (4), the solvent is at least one of dimethylformamide, dimethyl sulfoxide, methyl pyrrolidone and hexamethylphosphoric triamide;
preferably, in the step (4), the reaction is carried out in the presence of an organic base or an inorganic base, wherein the amount of the organic base or the inorganic base is not less than that of the intermediate 3;
preferably, in step (4), the reaction is carried out at 0-100 ℃; preferably 20 to 80 ℃;
preferably, in the step (4), the reaction is carried out under the protection of nitrogen or argon; coupling and oxidation of sulfydryl are reduced, and generation of impurities is further reduced;
preferably, in the step (5), the reducing agent is Raney Ni. The dosage of Raney Ni is more than one time of that of cholic acid, the actual utilization rate of Ranry Ni is low in the reaction, the dosage of Raney is greatly more than the theoretical consumption, and the yield and the speed of the reaction can be accepted only by adding more than 5mol of Raney Ni into each mol of substrate.
Preferably, Raney is used in an amount of: the Raney Ni is added in an amount of 5-20mol per mol of cholic acid substrate.
Preferably, in the step (5), the solvent is at least one of an alcohol solvent, a ketone solvent, a halogenated alkane solvent, an ether solvent or an amine solvent;
preferably, the alcoholic solvent is selected from methanol or ethanol; the ketone reagent is selected from acetone or butanone; the halogenated alkane solvent is dichloromethane or chloroform; the ether solvent is at least one of tetrahydrofuran, n-butyl ether, methyl tert-butyl ether and dioxane; the amine solvent is dimethylformamide or hexamethylphosphoric triamide;
preferably, in the step (5), the reduction desulfurization reaction is carried out at a temperature of 0-100 ℃;
preferably, in step (6), the reagent used for the reduction is 7- α -dehydrogenase;
preferably, in step (6), the reduction is carried out under catalytic hydrogenation conditions using a chiral ruthenium catalyst;
preferably, in step (6), the reagent used for the reduction is metallic sodium or metallic potassium.
Compared with the prior art, the invention has the following technical effects:
(1) the invention has mild reaction conditions, simple operation, good specificity and less byproducts, and the ursodeoxycholic acid prepared by the method has higher yield and purity;
(2) the use of the sulfhydryl nucleophilic reagent transforms the 12-carbon into a structure containing thioether groups, does not need oxidation, and has milder reaction conditions and lower cost;
(3) raney Ni is reduced and desulfurized in a solvent to realize direct reduction of hydroxyl to methylene, and further, protecting groups on 3-hydroxyl and ester protection of carboxyl are conveniently removed, so that next synthesis of ursodeoxycholic acid is carried out, the whole process flow is easy to realize, and industrial production is easy to realize.
Detailed Description
Example 1
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) cholic acid 4.08g (10mmol) was suspended in dichloromethane 100ml, after dissolution with stirring, PCC 2.8g (13mmol) was added, stirring at room temperature, the reaction was followed by TLC until consumption of cholic acid was complete, the reaction was stopped, rapid filtration was carried out using a silica gel plug to remove the black chromium salt and the silica gel layer was washed with dichloromethane 100 ml. Merging the filtrates; evaporation to dryness to give a brown cream solid as intermediate 1;
(2) dissolving the intermediate 1 in 100ml of methanol, adding 5 mu l of sulfuric acid, heating and refluxing, tracking by TLC after two hours until the esterification reaction is finished, evaporating the mixture of the esterification reaction to dryness, directly adding 20ml of acetic anhydride into viscous residue, slowly heating to 90 ℃, keeping the temperature at 90 ℃ for 2 hours, and tracking by TLC until the reaction is finished. The reaction mixture was cooled to room temperature, poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) the intermediate 2 is fully dried in a vacuum drying oven until the water content is lower than 0.1 percent, and then the next reaction can be carried out; dissolving dried intermediate 2 in dichloromethane 50ml, cooling to below 5 deg.C, adding methanesulfonyl chloride 2.2g
(11mmol), dropwise adding 2.2g (22mmol) of triethylamine, reacting at 2 ℃ after dropwise adding, tracking by TLC (thin layer chromatography) until the reaction is complete, adding 20ml of 5% sodium bicarbonate aqueous solution into the reaction system after the reaction is complete, stirring for layering, separating a dichloromethane layer, washing with water, and evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of dimethylformamide, adding 1.9g (15mmol) of benzylmercaptan and 1.5g (15mmol) of triethylamine, stirring at 25 ℃, reacting under the protection of nitrogen, tracking by TLC until the reaction is complete, after the reaction is complete, pouring the dimethylformamide solution into 200ml of water, stirring, filtering out a precipitated white solid, and fully washing with water to obtain an intermediate 4.
(5) The intermediate 4 is dissolved in 20ml of ethylene glycol dimethyl ether, 5.0g of Raney Ni is added, the reaction is carried out at 25 ℃, the TLC tracking is carried out, and the reaction is stopped when the raw material point disappears. Filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, adjusting the pH value of the solution to be acidic by adding hydrochloric acid after the hydrolysis reaction is completed, and separating out white solid to be filtered to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced in an alcohol solvent by using metal potassium, and then is acidified and purified to obtain ursodeoxycholic acid, wherein the yield is 91.6%, and the purity is 99.7%.
Example 2
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) suspending cholic acid 4.08g (10mmol) in n-pentanol 100ml water 10ml solvent, stirring for dissolving, adding 7- β dehydrogenase 0.5g (10mmol), stirring at room temperature, tracking reaction by TLC, stopping reaction until cholic acid is completely consumed, filtering with diatomite and microporous filter membrane to remove enzyme, washing silica gel layer with n-pentanol 50ml, combining filtrates, evaporating to dryness to obtain white pasty solid as intermediate 1;
(2) intermediate 1 was dissolved in 100ml of methanol, 5 μ l of sulfuric acid was added, followed by heating and refluxing, TLC tracking after two hours, the esterification reaction was completed, the mixture of this esterification reaction was evaporated to dryness, the viscous residue was added 100ml of dichloromethane, stirred to dissolve and cooled to below 0 ℃, 1.44g (12mmol) of pivaloyl chloride and 1.31g (13mmol) of triethylamine were added, followed by slow heating to room temperature and reaction at room temperature for 2 hours, TLC tracking reaction was completed. The reaction mixture was poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) fully drying the intermediate 2 in a vacuum drying oven until the water content is lower than 0.1%; dissolving the dried intermediate 2 in 50ml of trichloromethane, cooling to below 5 ℃, adding 5.64g (20mmol) of trifluoromethanesulfonic anhydride, dropwise adding 2.2g (22mmol) of triethylamine, reacting at 40 ℃ after the dropwise addition is finished, tracking by TLC (thin layer chromatography) until the reaction is complete, then adding 20ml of 5% sodium bicarbonate aqueous solution into the reaction system, stirring for layering, separating the trichloromethane layer, washing with water, and then evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of methyl pyrrolidone, adding 2.83g (30mmol) of ethylene glycol dithiol and 1.58g (11mmol) of tripropylamine, stirring at 100 ℃, carrying out reaction under the protection of argon, tracking by TLC until the reaction is complete, then pouring the methyl pyrrolidone solution into 200ml of water, stirring, filtering out precipitated white solid, and fully washing with water to obtain an intermediate 4.
(5) Dissolving the intermediate 4 in 20ml of butanone, adding Raney Ni4.3g, reacting at 2 ℃, tracking by TLC, stopping the reaction when the raw material point disappears, filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, completing the hydrolysis reaction, pouring the reaction mixture into 50ml of water, adding hydrochloric acid to adjust the pH value of the solution to be acidic, separating out white solid, and filtering to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced in an alcohol solvent by using 7- α -dehydrogenase, and then is acidified and purified to obtain ursodeoxycholic acid with the yield of 93.2% and the purity of 99.6%.
Example 3
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) suspending cholic acid 4.08g (10mmol) in dichloromethane 100ml, stirring to dissolve, adding PDC11.3g (30mmol), stirring at room temperature, tracking the reaction by TLC until the consumption of cholic acid is complete, stopping the reaction, rapidly filtering by using a silica gel plunger, removing black chromium salt, and washing the silica gel layer by using dichloromethane 100 ml. Merging the filtrates; evaporation to dryness to give a brown cream solid as intermediate 1;
(2) dissolving the intermediate 1 in 100ml of methanol, adding 5 mu l of sulfuric acid, heating and refluxing, tracking by TLC after two hours until the esterification reaction is finished, evaporating the mixture of the esterification reaction to dryness, directly adding 20ml of acetic anhydride into viscous residue, slowly heating to 90 ℃, keeping the temperature at 90 ℃ for 2 hours, and tracking by TLC until the reaction is finished. The reaction mixture was cooled to room temperature, poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) the intermediate 2 is fully dried in a vacuum drying oven until the water content is lower than 0.1 percent, and then the next reaction can be carried out; dissolving the dried intermediate 2 in 50ml of dichloromethane, cooling to below 5 ℃, adding 2.2g (11mmol) of methane sulfonyl chloride, dropwise adding 2.2g (22mmol) of triethylamine, reacting at 2 ℃ after dropwise adding, tracking by TLC (thin layer chromatography) until the reaction is complete, adding 20ml of 5% sodium bicarbonate aqueous solution into a reaction system after the reaction is complete, stirring for layering, separating a dichloromethane layer, washing with water, and evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of dimethylformamide, adding 1.1g (10mmol) of thiophenol and 1.5g (15mmol) of triethylamine, stirring at 1 ℃, reacting under the protection of nitrogen, tracking by TLC (thin layer chromatography) until the reaction is complete, then pouring the dimethylformamide solution into 200ml of water, stirring, filtering out a precipitated white solid, and fully washing with water to obtain an intermediate 4;
(5) the intermediate 4 was dissolved in 20ml of hexamethylphosphoric triamide, 17.0g of Raney Ni was added, the reaction was carried out at 100 ℃ and the reaction was stopped when the starting material point disappeared by TLC tracing. Filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, adjusting the pH value of the solution to be acidic by adding hydrochloric acid after the hydrolysis reaction is completed, and separating out white solid to be filtered to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced by using a chiral ruthenium catalyst under the condition of catalytic hydrogenation, and then is acidified and purified to obtain ursodeoxycholic acid, wherein the yield is 92.8% and the purity is 99.8%.
Comparative example 1 (different amount of thiol nucleophile compared to example 1)
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) cholic acid 4.08g (10mmol) was suspended in dichloromethane 100ml, after dissolution with stirring, PCC 2.8g (13mmol) was added, stirring at room temperature, the reaction was followed by TLC until consumption of cholic acid was complete, the reaction was stopped, rapid filtration was carried out using a silica gel plug to remove the black chromium salt and the silica gel layer was washed with dichloromethane 100 ml. Merging the filtrates; evaporation to dryness to give a brown cream solid as intermediate 1;
(2) dissolving the intermediate 1 in 100ml of methanol, adding 5 mu l of sulfuric acid, heating and refluxing, tracking by TLC after two hours until the esterification reaction is finished, evaporating the mixture of the esterification reaction to dryness, directly adding 20ml of acetic anhydride into viscous residue, slowly heating to 90 ℃, keeping the temperature at 90 ℃ for 2 hours, and tracking by TLC until the reaction is finished. The reaction mixture was cooled to room temperature, poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) the intermediate 2 is fully dried in a vacuum drying oven until the water content is lower than 0.1 percent, and then the next reaction can be carried out; dissolving the dried intermediate 2 in 50ml of dichloromethane, cooling to below 5 ℃, adding 2.2g (11mmol) of methane sulfonyl chloride, dropwise adding 2.2g (22mmol) of triethylamine, reacting at 2 ℃ after dropwise adding, tracking by TLC (thin layer chromatography) until the reaction is complete, adding 20ml of 5% sodium bicarbonate aqueous solution into a reaction system after the reaction is complete, stirring for layering, separating a dichloromethane layer, washing with water, and evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of dimethylformamide, adding 1.18g (9.5mmol) of benzylmercaptan and 1.5g (15mmol) of triethylamine, stirring at 25 ℃, reacting under the protection of nitrogen, tracking by TLC until the reaction is complete, after the reaction is complete, pouring the dimethylformamide solution into 200ml of water, stirring, filtering out a precipitated white solid, and fully washing with water to obtain an intermediate 4.
(5) The intermediate 4 is dissolved in 20ml of ethylene glycol dimethyl ether, 5.0g of Raney Ni is added, the reaction is carried out at 25 ℃, the TLC tracking is carried out, and the reaction is stopped when the raw material point disappears. Filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, adjusting the pH value of the solution to be acidic by adding hydrochloric acid after the hydrolysis reaction is completed, and separating out white solid to be filtered to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced in an alcohol solvent by using metal potassium, and then is acidified and purified to obtain ursodeoxycholic acid, wherein the yield is 77% and the purity is 91.1%.
Comparative example 2 (different Raney Ni reducing agent than in example 1)
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) cholic acid 4.08g (10mmol) was suspended in dichloromethane 100ml, after dissolution with stirring, PCC 2.8g (13mmol) was added, stirring at room temperature, the reaction was followed by TLC until consumption of cholic acid was complete, the reaction was stopped, rapid filtration was carried out using a silica gel plug to remove the black chromium salt and the silica gel layer was washed with dichloromethane 100 ml. Merging the filtrates; evaporation to dryness to give a brown cream solid as intermediate 1;
(2) dissolving the intermediate 1 in 100ml of methanol, adding 5 mu l of sulfuric acid, heating and refluxing, tracking by TLC after two hours until the esterification reaction is finished, evaporating the mixture of the esterification reaction to dryness, directly adding 20ml of acetic anhydride into viscous residue, slowly heating to 90 ℃, keeping the temperature at 90 ℃ for 2 hours, and tracking by TLC until the reaction is finished. The reaction mixture was cooled to room temperature, poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) the intermediate 2 is fully dried in a vacuum drying oven until the water content is lower than 0.1 percent, and then the next reaction can be carried out; dissolving the dried intermediate 2 in 50ml of dichloromethane, cooling to below 5 ℃, adding 2.2g (11mmol) of methane sulfonyl chloride, dropwise adding 2.2g (22mmol) of triethylamine, reacting at 2 ℃ after dropwise adding, tracking by TLC (thin layer chromatography) until the reaction is complete, adding 20ml of 5% sodium bicarbonate aqueous solution into a reaction system after the reaction is complete, stirring for layering, separating a dichloromethane layer, washing with water, and evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of dimethylformamide, adding 1.9g (15mmol) of benzylmercaptan and 1.5g (15mmol) of triethylamine, stirring at 25 ℃, reacting under the protection of nitrogen, tracking by TLC until the reaction is complete, after the reaction is complete, pouring the dimethylformamide solution into 200ml of water, stirring, filtering out a precipitated white solid, and fully washing with water to obtain an intermediate 4.
(5) The intermediate 4 is dissolved in 20ml of ethylene glycol dimethyl ether, 2.0g of Raney Ni is added, the reaction is carried out at 25 ℃, the TLC tracking is carried out, and the reaction is stopped when the raw material point disappears. Filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, adjusting the pH value of the solution to be acidic by adding hydrochloric acid after the hydrolysis reaction is completed, and separating out white solid to be filtered to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced in an alcohol solvent by using metal potassium, and then is acidified and purified to obtain ursodeoxycholic acid, wherein the yield is 75% and the purity is 92.9%.
Comparative example 3 (different reaction conditions compared to example 1)
A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) cholic acid 4.08g (10mmol) was suspended in dichloromethane 100ml, after dissolution with stirring, PCC 2.8g (13mmol) was added, stirring at room temperature, the reaction was followed by TLC until consumption of cholic acid was complete, the reaction was stopped, rapid filtration was carried out using a silica gel plug to remove the black chromium salt and the silica gel layer was washed with dichloromethane 100 ml. Merging the filtrates; evaporation to dryness to give a brown cream solid as intermediate 1;
(2) dissolving the intermediate 1 in 100ml of methanol, adding 5 mu l of sulfuric acid, heating and refluxing, tracking by TLC after two hours until the esterification reaction is finished, evaporating the mixture of the esterification reaction to dryness, directly adding 20ml of acetic anhydride into viscous residue, slowly heating to 60 ℃, keeping the temperature at 60 ℃ for 2 hours, and tracking by TLC until the reaction is finished. The reaction mixture was cooled to room temperature, poured into 200ml of water, and the precipitated white solid was filtered off and then recrystallized using methanol, or silica gel column chromatography, with dichloromethane: 50 parts of methanol: 1, passing through a column to obtain a relatively pure intermediate 2;
(3) the intermediate 2 is fully dried in a vacuum drying oven until the water content is lower than 0.1 percent, and then the next reaction can be carried out; dissolving the dried intermediate 2 in 50ml of dichloromethane, cooling to below 5 ℃, adding 2.2g (11mmol) of methane sulfonyl chloride, dropwise adding 2.2g (22mmol) of triethylamine, reacting at 2 ℃ after dropwise adding, tracking by TLC (thin layer chromatography) until the reaction is complete, adding 20ml of 5% sodium bicarbonate aqueous solution into a reaction system after the reaction is complete, stirring for layering, separating a dichloromethane layer, washing with water, and evaporating to dryness to obtain an intermediate 3;
(4) dissolving the intermediate 3 in 50ml of dimethylformamide, adding 1.9g (15mmol) of benzylmercaptan and 1.5g (15mmol) of triethylamine, stirring at 25 ℃, reacting under the protection of nitrogen, tracking by TLC until the reaction is complete, after the reaction is complete, pouring the dimethylformamide solution into 200ml of water, stirring, filtering out a precipitated white solid, and fully washing with water to obtain an intermediate 4.
(5) The intermediate 4 is dissolved in 20ml of ethylene glycol dimethyl ether, 5.0g of Raney Ni is added, the reaction is carried out at 25 ℃, the TLC tracking is carried out, and the reaction is stopped when the raw material point disappears. Filtering the reaction mixture to remove black nickel slag, adding 50ml of methanol and 20ml of 40% sodium hydroxide aqueous solution into the filtrate, reacting for 2 hours at 25 ℃, tracking by TLC, adjusting the pH value of the solution to be acidic by adding hydrochloric acid after the hydrolysis reaction is completed, and separating out white solid to be filtered to obtain an intermediate 5 (7-ketocholic acid);
(6) the intermediate 5 is reduced by using metal potassium in an alcohol solvent, and then is acidified and purified to obtain ursodeoxycholic acid, wherein the yield is 83.2 percent, and the purity is 94.3 percent.
The embodiment shows that the synthetic method of ursodeoxycholic acid provided by the invention has high yield and purity, and is a simple and efficient synthetic process.
The above detailed description is specific to one possible embodiment of the present invention, and the embodiment is not intended to limit the scope of the present invention, and all equivalent implementations or modifications without departing from the scope of the present invention should be included in the technical scope of the present invention.
Claims (12)
1. A synthetic method of ursodeoxycholic acid comprises the following preparation methods:
(1) dissolving cholic acid in solvent, adding oxidant, reacting to obtain intermediate 1
(2) Adding the intermediate 1 into an alcohol solvent for esterification reaction, evaporating the solvent after the reaction, and adding an acylation reagent for reaction to obtain an intermediate 2;
(3) dissolving the dried intermediate 2 in an organic solvent, adding a sulfonylation reagent for reaction to obtain an intermediate 3;
(4) dissolving the intermediate 3 in a solvent, adding a sulfhydryl nucleophilic reagent, and reacting to obtain an intermediate 4;
(5) dissolving the intermediate 4 in a solvent, adding a reducing agent, carrying out reduction desulfurization reaction, filtering to obtain a filtrate, adding alcohol and alkali into the filtrate, carrying out hydrolysis reaction, and then carrying out acidification treatment to obtain an intermediate 5;
(6) adding the intermediate 5 into an alcohol solvent, and carrying out reduction reaction to obtain a final product ursodeoxycholic acid;
wherein, in the step (1), the oxidant is PCC, PDC or 7- β dehydrogenase.
2. The method for synthesizing ursodeoxycholic acid according to claim 1, wherein in the step (1), the molar ratio of the oxidant to cholic acid is 1-3: 1.
3. the method for synthesizing ursodeoxycholic acid according to claim 2, wherein in the step (2), the mole ratio of the acylating agent to cholic acid is 10-30: 1; the reaction temperature after the addition of the acylating agent is 90-100 ℃.
4. The method for synthesizing ursodeoxycholic acid according to claim 3, wherein in the step (3), the sulfonylation reagent is at least one of tosyl chloride, benzenesulfonyl chloride, methanesulfonyl chloride, and trifluoromethanesulfonic anhydride; in the step (3), the dosage of the sulfonylation reagent is 1-2: 1; in the step (3), the reaction temperature is 0-40 ℃.
5. The method of claim 4, wherein the sulfonylating agent is trifluoromethanesulfonic anhydride.
6. The method according to any one of claims 1 to 5, wherein in step (4), the thiol nucleophile is at least one of methyl mercaptan, ethyl mercaptan, propyl mercaptan, benzyl mercaptan, thiophenol, 2-mercaptobenzothiazole, 5-phenyl-mercaptotetrazole, 5-methylmercaptotetrazole, 2-mercaptopyridine, thioglycolic acid and thioglycolate, mercaptopropanol, dimercaptopropanol, ethanedithiol, and propanedithiol.
7. The method according to claim 6, wherein in the step (4), the thiol nucleophile is at least one of 2-mercaptobenzothiazole, 5-phenyl-mercaptotetrazole, 5-methylmercaptotetrazole, and 2-mercaptopyridine; the molar ratio of the sulfhydryl nucleophilic reagent to the cholic acid is 1-3: 1; the solvent is at least one of dimethylformamide, dimethyl sulfoxide, methyl pyrrolidone and hexamethylphosphoric triamide.
8. The method for synthesizing ursodeoxycholic acid according to claim 6, wherein in the step (4), the reaction is carried out in the presence of an organic base or an inorganic base, wherein the amount of the organic base or the inorganic base is not less than that of the intermediate 3; the reaction is carried out at 0-100 ℃; the reaction is carried out under the protection of nitrogen or argon.
9. The method for synthesizing ursodeoxycholic acid according to claim 8, wherein, in the step (4), the reaction is performed at 20-80 ℃.
10. The method for synthesizing ursodeoxycholic acid according to claim 8, wherein, in the step (5), said reducing agent is Raney Ni; the dosage of the reducing agent is not less than that of the intermediate 4;
the solvent is at least one of an alcohol solvent, a ketone solvent, a halogenated alkane solvent, an ether solvent or an amine solvent;
the alcohol solvent is selected from methanol or ethanol; the ketone reagent is selected from acetone or butanone; the halogenated alkane solvent is dichloromethane or chloroform;
the ether solvent is at least one of tetrahydrofuran, n-butyl ether, methyl tert-butyl ether and dioxane; the amine solvent is dimethylformamide or hexamethylphosphoric triamide;
the reduction desulfurization reaction is carried out at the temperature of 0-100 ℃.
11. The method for synthesizing ursodeoxycholic acid according to claim 10, wherein in the step (6), the reagent used for the reduction is at least one of 7- α -dehydrogenase, metallic sodium, and metallic potassium.
12. The method for synthesizing ursodeoxycholic acid according to claim 10, wherein in the step (6), said reduction is performed under catalytic hydrogenation conditions using a chiral ruthenium catalyst.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910657023.2A CN110305178B (en) | 2019-07-19 | 2019-07-19 | Synthetic method of ursodeoxycholic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910657023.2A CN110305178B (en) | 2019-07-19 | 2019-07-19 | Synthetic method of ursodeoxycholic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110305178A CN110305178A (en) | 2019-10-08 |
CN110305178B true CN110305178B (en) | 2020-07-03 |
Family
ID=68080482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910657023.2A Active CN110305178B (en) | 2019-07-19 | 2019-07-19 | Synthetic method of ursodeoxycholic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110305178B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108299540A (en) * | 2017-12-28 | 2018-07-20 | 广州市盈宇医药科技有限公司 | A kind of synthetic method of Tauro ursodesoxy cholic acid |
-
2019
- 2019-07-19 CN CN201910657023.2A patent/CN110305178B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108299540A (en) * | 2017-12-28 | 2018-07-20 | 广州市盈宇医药科技有限公司 | A kind of synthetic method of Tauro ursodesoxy cholic acid |
Also Published As
Publication number | Publication date |
---|---|
CN110305178A (en) | 2019-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109762043A (en) | Chenodeoxycholic acid and preparation method thereof | |
CN101279997B (en) | Novel preparation of budesonide | |
CN101215308B (en) | Method for producing ursodeoxycholic acid by using swine bladder as raw material | |
CN101351470B (en) | Purification process for chenodeoxycholic acid | |
CN101987860B (en) | Preparation method of ursodesoxycholic acid | |
CN103319560A (en) | Preparation method of ursodeoxycholic acid | |
CN100540561C (en) | A kind of synthetic method of chenodeoxycholic acid | |
CN111233961A (en) | Preparation method of ursodeoxycholic acid | |
CN107312054A (en) | A kind of method that urso and Tauro ursodesoxy cholic acid are synthesized from pig's bile | |
CN109369765A (en) | A kind of preparation method of murine cholic acid | |
CN108676014A (en) | The method for purifying the method for everolimus intermediate and preparing everolimus | |
CN110305178B (en) | Synthetic method of ursodeoxycholic acid | |
CN108299540A (en) | A kind of synthetic method of Tauro ursodesoxy cholic acid | |
CN106916196A (en) | A kind of synthetic method of shellfish cholic acid intermediate difficult to understand | |
CN102453071B (en) | The preparation method of extracting directly synthesis Chenodiol and ursodesoxycholic acid from Fel Sus domestica unguentum or tankage | |
EP1966228B1 (en) | Purification process for chenodeoxycholic acid | |
CN102746359B (en) | A kind of synthetic method being prepared ursodesoxycholic acid by Chenodiol | |
CN115611962B (en) | Method for synthesizing cholic acid | |
CN106831923B (en) | A kind of preparation method of chenodeoxycholic acid | |
CN107383137A (en) | A kind of synthetic method of chenodeoxycholic acid | |
CN110204587B (en) | Synthetic method of obeticholic acid | |
CN115626944B (en) | Cholic acid intermediate A5 and preparation method thereof | |
CN115536720B (en) | Cholic acid intermediate A8 and preparation method thereof | |
CN115651049B (en) | Cholic acid intermediate A3 and preparation method thereof | |
CN116023424B (en) | Cholic acid intermediate A4 and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 28, Jiuzhou Avenue, Torch Development Zone, Zhongshan City, Guangdong Province Patentee after: Zhongshan bailing Biotechnology Co.,Ltd. Address before: No. 28, Jiuzhou Avenue, Torch Development Zone, Zhongshan City, Guangdong Province Patentee before: ZHONGSHAN BELLING BIOTECHNOLOGY Co.,Ltd. |